-
1
-
-
0003964363
-
-
American Cancer Society Atlanta: American Cancer Society. 2008.
-
American Cancer Society. Cancer Facts & Figures 2008. Atlanta: American Cancer Society. 2008.
-
(2008)
Cancer Facts Figures
-
-
-
2
-
-
0003719393
-
-
Abraham J, Allegra CJ, Gulley JL, eds 2nd ed. Philadelphia: Lippincott Williams & Wilkins
-
Abraham J, Allegra CJ, Gulley JL, eds. Bethesda Handbook of Clinical Oncology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2005.
-
(2005)
Bethesda Handbook of Clinical Oncology
-
-
-
3
-
-
20544455590
-
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
-
DOI 10.1056/NEJMoa043623
-
Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-2597. (Pubitemid 41007845)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.25
, pp. 2589-2597
-
-
Winton, T.1
Livingston, R.2
Johnson, D.3
Rigas, J.4
Johnston, M.5
Butts, C.6
Cormier, Y.7
Goss, G.8
Inculet, R.9
Vallieres, E.10
Fry, W.11
Bethune, D.12
Ayoub, J.13
Ding, K.14
Seymour, L.15
Graham, B.16
Tsao, M.-S.17
Gandara, D.18
Kesler, K.19
Demmy, T.20
Shepherd, F.21
more..
-
5
-
-
50349091770
-
Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: Effects of docetaxel on immune enhancement
-
Garnett CT, Schlom J, Hodge JW. Combination of docetaxel and recombinant vaccine enhances T-cell responses and antitumor activity: Effects of docetaxel on immune enhancement. Clin Cancer Res 2008;14:3536-3544.
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 3536-3544
-
-
Garnett, C.T.1
Schlom, J.2
Hodge, J.W.3
-
6
-
-
70349416505
-
Vaccines for the treatment of non-small cell lung cancer: A renewed anticancer strategy
-
Gridelli C, Rossi A, Maione P, et al. Vaccines for the treatment of non-small cell lung cancer: A renewed anticancer strategy. Oncologist 2009;14:909-920.
-
(2009)
Oncologist
, vol.14
, pp. 909-920
-
-
Gridelli, C.1
Rossi, A.2
Maione, P.3
-
7
-
-
68549135290
-
Integrated data from 2 randomized double-blind placebo-controlled phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
-
Higano CS, Schellhammer PF, Small EJ, et al. Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer 2009;115:3670-3679.
-
(2009)
Cancer
, vol.115
, pp. 3670-3679
-
-
Higano, C.S.1
Schellhammer, P.F.2
Small, E.J.3
-
8
-
-
80054701176
-
Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccinemediated antitumor responses
-
Gameiro SR, Caballero JA, Higgins JP, et al. Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccinemediated antitumor responses. Cancer Immunol Immunother 2011;60:1227-1242.
-
(2011)
Cancer Immunol. Immunother
, vol.60
, pp. 1227-1242
-
-
Gameiro, S.R.1
Caballero, J.A.2
Higgins, J.P.3
-
9
-
-
79951826832
-
Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: The growth rate constant as an indicator of therapeutic efficacy
-
Stein WD, Gulley JL, Schlom J, et al. Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: The growth rate constant as an indicator of therapeutic efficacy. Clin Cancer Res 2011;17:907-917.
-
(2011)
Clin. Cancer Res.
, vol.17
, pp. 907-917
-
-
Stein, W.D.1
Gulley, J.L.2
Schlom, J.3
-
10
-
-
33645669207
-
Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis
-
Gelbard A, Garnett CT, Abrams SI, et al. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Clin Cancer Res 2006;12:1897-1905.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 1897-1905
-
-
Gelbard, A.1
Garnett, C.T.2
Abrams, S.I.3
-
11
-
-
0029042336
-
Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
-
Tsang KY, Zaremba S, Nieroda CA, et al. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine. J Natl Cancer Inst 1995; 87:982-990.
-
(1995)
J. Natl. Cancer Inst.
, vol.87
, pp. 982-990
-
-
Tsang, K.Y.1
Zaremba, S.2
Nieroda, C.A.3
-
12
-
-
7444258053
-
Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes
-
DOI 10.1158/0008-5472.CAN-04-1525
-
Garnett CT, Palena C, Chakraborty M, et al. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 2004;64:7985-7994. (Pubitemid 39446933)
-
(2004)
Cancer Research
, vol.64
, Issue.21
, pp. 7985-7994
-
-
Garnett, C.T.1
Palena, C.2
Chakarborty, M.3
Tsang, K.-Y.4
Schlom, J.5
Hodge, J.W.6
-
13
-
-
0031726919
-
Population pharmacokinetics and pharmacodynamics of cisplatin in patients with cancer: Analysis with the NONMEM program
-
Nagai N, Ogata H, Wada Y, et al. Population pharmacokinetics and pharmacodynamics of cisplatin in patients with cancer: Analysis with the NONMEM program. J Clin Pharmacol 1998;38:1025-1034. (Pubitemid 28524450)
-
(1998)
Journal of Clinical Pharmacology
, vol.38
, Issue.11
, pp. 1025-1034
-
-
Nagai, N.1
Ogata, H.2
Wada, Y.3
Tsujino, D.4
Someya, K.5
Ohno, T.6
Masuhara, K.7
Tanaka, Y.8
Takahashi, H.9
Nagai, H.10
Kato, K.11
Koshiba, Y.12
Igarashi, T.13
Yokoyama, A.14
Kinameri, K.15
Kato, T.16
Kurita, Y.17
-
14
-
-
34247117387
-
Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokineactivated killer cells
-
Law KS, Chen HC, Liao SK. Non-cytotoxic and sublethal paclitaxel treatment potentiates the sensitivity of cultured ovarian tumor SKOV-3 cells to lysis by lymphokineactivated killer cells. Anticancer Res 2007;27:841-850.
-
(2007)
Anticancer Res.
, vol.27
, pp. 841-850
-
-
Law, K.S.1
Chen, H.C.2
Liao, S.K.3
-
15
-
-
38949174590
-
Cisplatin up-regulates ICAM-1 expression in endothelial cell via a NF-κB dependent pathway
-
DOI 10.1111/j.1349-7006.2008.00696.x
-
Yu M, Han J, Cui P, et al. Cisplatin up-regulates ICAM-1 expression in endothelial cell via a NF-kappaB dependent pathway. Cancer Sci 2008;99:391-397. (Pubitemid 351228497)
-
(2008)
Cancer Science
, vol.99
, Issue.2
, pp. 391-397
-
-
Yu, M.1
Han, J.2
Cui, P.3
Dai, M.4
Li, H.5
Zhang, J.6
Xiu, R.7
-
16
-
-
33846997837
-
Effects of cisplatin alpha-interferon and 13-cis retinoic acid on the expression of Fas CD95 intercellular adhesion molecule-1 ICAM-1 and epidermal growth factor receptor EGFR in oral cancer cell lines
-
Sundelin K, Roberg K, Grenman R, Hakansson L. Effects of cisplatin, alpha-interferon, and 13-cis retinoic acid on the expression of Fas (CD95), intercellular adhesion molecule-1 (ICAM-1), and epidermal growth factor receptor (EGFR) in oral cancer cell lines. J Oral Pathol Med 2007;36:177-183.
-
(2007)
J. Oral. Pathol. Med.
, vol.36
, pp. 177-183
-
-
Sundelin, K.1
Roberg, K.2
Grenman, R.3
Hakansson, L.4
-
17
-
-
0028486130
-
Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes
-
Kojima H, Shinohara N, Hanaoka S, et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1994;1:357-364.
-
(1994)
Immunity
, vol.1
, pp. 357-364
-
-
Kojima, H.1
Shinohara, N.2
Hanaoka, S.3
-
18
-
-
0037570795
-
Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy
-
DOI 10.1159/000070658
-
Modrak DE, Gold DV, Goldenberg DM, Blumenthal RD. Colonic tumor CEA, CSAp and MUC-1 expression following radioimmunotherapy or chemotherapy. Tumour Biol 2003; 24:32-39. (Pubitemid 36578816)
-
(2003)
Tumor Biology
, vol.24
, Issue.1
, pp. 32-39
-
-
Modrak, D.E.1
Gold, D.V.2
Goldenberg, D.M.3
Blumenthal, R.D.4
-
19
-
-
52949085860
-
Combined effects of 5-fluorouracil folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: Pharmacological basis to develop an active antitumor immunochemotherapy
-
Prete SP, Turriziani M, Massara MC, et al. Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: Pharmacological basis to develop an active antitumor immunochemotherapy. J Exp Clin Cancer Res 2008;27:5.
-
(2008)
J. Exp. Clin. Cancer Res.
, vol.27
, pp. 5
-
-
Prete, S.P.1
Turriziani, M.2
Massara, M.C.3
-
20
-
-
0038069515
-
MHC class i antigens, immune surveillance, and tumor immune escape
-
DOI 10.1002/jcp.10290
-
Garcia-Lora A, Algarra I, Garrido F. MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 2003;195:346-355. (Pubitemid 36529863)
-
(2003)
Journal of Cellular Physiology
, vol.195
, Issue.3
, pp. 346-355
-
-
Garcia-Lora, A.1
Algarra, I.2
Garrido, F.3
-
21
-
-
0033973608
-
Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine
-
Zhu MZ, Marshall J, Cole D, et al. Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine. Clin Cancer Re 2000;6: 24-33. (Pubitemid 30064972)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.1
, pp. 24-33
-
-
Zhu, M.1
Marshall, J.2
Cole, D.3
Schlom, J.4
Tsang, K.Y.5
-
22
-
-
0028110928
-
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
-
Kagi D, Vignaux F, Ledermann B, et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994;265:528-530. (Pubitemid 24264998)
-
(1994)
Science
, vol.265
, Issue.5171
, pp. 528-530
-
-
Kagi, D.1
Vignaux, F.2
Ledermann, B.3
Burki, K.4
Depraetere, V.5
Nagata, S.6
Hengartner, H.7
Golstein, P.8
-
23
-
-
0030005837
-
Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity
-
Kataoka T, Shinohara N, Takayama H, et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996;156:3678-3686. (Pubitemid 26139940)
-
(1996)
Journal of Immunology
, vol.156
, Issue.10
, pp. 3678-3686
-
-
Kataoka, T.1
Shinohara, N.2
Takayama, H.3
Takaku, K.4
Kondo, S.5
Yonehara, S.6
Nagai, K.7
-
24
-
-
0038819943
-
Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-κB through the Akt pathway
-
DOI 10.1074/jbc.M211695200
-
Mayo MW, Denlinger CE, Broad RM, et al. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J Biol Chem 2003;278:18980-18989. (Pubitemid 36799282)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.21
, pp. 18980-18989
-
-
Mayo, M.W.1
Denlinger, C.E.2
Broad, R.M.3
Yeung, F.4
Reilly, E.T.5
Shi, Y.6
Jones, D.R.7
-
25
-
-
80053326169
-
Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
-
Wang Y, Qu Y, Niu XL, et al. Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cytokine 2011;56:365-375.
-
(2011)
Cytokine
, vol.56
, pp. 365-375
-
-
Wang, Y.1
Qu, Y.2
Niu, X.L.3
-
26
-
-
77549083441
-
Transforming growth factor beta TGFbeta and inflammation in cancer
-
Bierie B, Moses HL. Transforming growth factor beta (TGFbeta) and inflammation in cancer. Cytokine Growth Factor Rev 2010;21:49-59.
-
(2010)
Cytokine Growth Factor Rev.
, vol.21
, pp. 49-59
-
-
Bierie, B.1
Moses, H.L.2
-
27
-
-
72549116879
-
Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma
-
Yanagawa J, Walser TC, Zhu LX, et al. Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin Cancer Res 2009;15:6820-6829.
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 6820-6829
-
-
Yanagawa, J.1
Walser, T.C.2
Zhu, L.X.3
-
29
-
-
79955753093
-
Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis
-
Chen C, Fu X, Zhang D, et al. Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis. Int J Biol Sci 2011;7:551-566.
-
(2011)
Int. J. Biol. Sci.
, vol.7
, pp. 551-566
-
-
Chen, C.1
Fu, X.2
Zhang, D.3
-
31
-
-
65749116421
-
The effect of vinca alkaloid anticancer drug vinorelbine on chromatin and histone proteins in solution
-
Rabbani-Chadegani A, Chamani E, Hajihassan Z. The effect of vinca alkaloid anticancer drug, vinorelbine, on chromatin and histone proteins in solution. Eur J Pharmacol 2009;613: 34-38.
-
(2009)
Eur.J.Pharmacol.
, vol.613
, pp. 34-38
-
-
Rabbani-Chadegani, A.1
Chamani, E.2
Hajihassan, Z.3
-
32
-
-
33746268092
-
A two-hit mechanism for pre-mitotic arrest of cancer cell proliferation by a polyamide-alkylator conjugate
-
Alvarez D, Chou CJ, Latella L, et al. A two-hit mechanism for pre-mitotic arrest of cancer cell proliferation by a polyamide-alkylator conjugate. Cell Cycle 2006;5: 1537-1548. (Pubitemid 44091975)
-
(2006)
Cell Cycle
, vol.5
, Issue.14
, pp. 1537-1548
-
-
Alvarez, D.1
James Chou, C.2
Latella, L.3
Zeitlin, S.G.4
Ku, S.5
Puri, P.L.6
Dervan, P.B.7
Gottesfeld, J.M.8
-
33
-
-
34248664108
-
Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma
-
DOI 10.1002/hep.21578
-
Wong CM, Ng YL, Lee JM, et al. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 2007;45:1129-1138. (Pubitemid 46775774)
-
(2007)
Hepatology
, vol.45
, Issue.5
, pp. 1129-1138
-
-
Wong, C.-M.1
Ng, Y.-L.2
Lee, J.M.-F.3
Wong, C.C.-L.4
Cheung, O.-F.5
Chan, C.-Y.6
Tung, E.K.-K.7
Ching, Y.-P.8
Ng, I.O.-L.9
-
34
-
-
69749112731
-
PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis
-
Chipuk JE, Green DR. PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis. Cell Cycle 2009;8:2692-2696.
-
(2009)
Cell Cycle
, vol.8
, pp. 2692-2696
-
-
Chipuk, J.E.1
Green, D.R.2
-
37
-
-
78650591943
-
BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells
-
Xu JD, Cao XX, Long ZW, et al. BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells. J Pathol 2011;223:400-409.
-
(2011)
J. Pathol.
, vol.223
, pp. 400-409
-
-
Xu, J.D.1
Cao, X.X.2
Long, Z.W.3
-
38
-
-
80051525374
-
Interleukin 1alpha sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancerassociated fibroblasts
-
Tjomsland V, Spangeus A, Vä lilä J, et al. Interleukin 1alpha sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancerassociated fibroblasts. Neoplasia 2011;13:664-675.
-
(2011)
Neoplasia
, vol.13
, pp. 664-675
-
-
Tjomsland, V.1
Spangeus, A.2
Välilä, J.3
-
39
-
-
66349109431
-
Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB
-
Melisi D, Niu J, Chang Z, et al. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB. Molec Cancer Res 2009;7:624-633.
-
(2009)
Molec. Cancer Res.
, vol.7
, pp. 624-633
-
-
Melisi, D.1
Niu, J.2
Chang, Z.3
-
40
-
-
79960920666
-
Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells
-
Kaneno R, Shurin GV, Kaneno FM, et al. Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells. Cell Oncol (Dordr) 2011;34:97-106.
-
(2011)
Cell Oncol. Dordr.
, vol.34
, pp. 97-106
-
-
Kaneno, R.1
Shurin, G.V.2
Kaneno, F.M.3
-
41
-
-
77951178310
-
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
-
Ramakrishnan R, Assudani D, Nagaraj S, et al. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice. J Clin Invest 2010;120:1111-1124.
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 1111-1124
-
-
Ramakrishnan, R.1
Assudani, D.2
Nagaraj, S.3
-
42
-
-
79952390627
-
Immune parameters affecting the efficacy of chemotherapeutic regimens
-
Zitvogel L, Kepp O, Kroemer G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol 2011;8:151-160.
-
(2011)
Nat. Rev. Clin. Oncol.
, vol.8
, pp. 151-160
-
-
Zitvogel, L.1
Kepp, O.2
Kroemer, G.3
-
43
-
-
68349123372
-
Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism
-
Shurin GV, Tourkova IL, Kaneno R, Shurin MR. Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism. J Immunol 2009;183:137-144.
-
(2009)
J. Immunol.
, vol.183
, pp. 137-144
-
-
Shurin, G.V.1
Tourkova, I.L.2
Kaneno, R.3
Shurin, M.R.4
-
44
-
-
0344924989
-
Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer
-
DOI 10.1016/S0022-5223(03)00707-4
-
Merritt RE, Mahtabifard A, Yamada RE, et al. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer. J Thorac Cardiovasc Surg 2003;126:1609-1617. (Pubitemid 37449195)
-
(2003)
Journal of Thoracic and Cardiovascular Surgery
, vol.126
, Issue.5
, pp. 1609-1617
-
-
Merritt, R.E.1
Mahtabifard, A.2
Yamada, R.E.3
Crystal, R.G.4
Korst, R.J.5
-
45
-
-
0028678979
-
Lymphocyte binding to K562 cells: Effect of target cell irradiation and correlation with ICAM-1 and LFA-3 expression
-
Zamai L, Rana R, Mazzotti G, et al. Lymphocyte binding to K562 cells: Effect of target cell irradiation and correlation with ICAM-1 and LFA-3 expression. Eur J Histochem 1994; 38 (suppl 1):53-60.
-
(1994)
Eur. J. Histochem.
, vol.38
, Issue.1
, pp. 53-60
-
-
Zamai, L.1
Rana, R.2
Mazzotti, G.3
-
46
-
-
0032843881
-
How tumors escape immune destruction and what we can do about it
-
DOI 10.1007/s002620050590
-
Gilboa E. How tumors escape immune destruction and what we can do about it. Cancer Immunol Immunother 1999; 48:382-385. (Pubitemid 29461391)
-
(1999)
Cancer Immunology Immunotherapy
, vol.48
, Issue.7
, pp. 382-385
-
-
Gilboa, E.1
-
47
-
-
0345801302
-
Tumour MHC class i downregulation and immunotherapy Review
-
Bubenik J. Tumour MHC class I downregulation and immunotherapy (Review). Oncol Rep 2003;10:2005-2008.
-
(2003)
Oncol. Rep.
, vol.10
, pp. 2005-2008
-
-
Bubenik, J.1
-
49
-
-
0032945057
-
Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-κB independent pathway
-
DOI 10.1038/sj.bjc.6690449
-
Takizawa K, Kamijo R, Ito D, et al. Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway. Br J Cancer 1999;80:954-963. (Pubitemid 29233915)
-
(1999)
British Journal of Cancer
, vol.80
, Issue.7
, pp. 954-963
-
-
Takizawa, K.1
Kamijo, R.2
Ito, D.3
Hatori, M.4
Sumitani, K.5
Nagumo, M.6
-
50
-
-
12644305917
-
Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines
-
Loprevite M, Varesco L, Favoni R, et al. Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines. Int J Oncol 1997;11:1203-1208. (Pubitemid 27502072)
-
(1997)
International Journal of Oncology
, vol.11
, Issue.6
, pp. 1203-1208
-
-
Loprevite, M.1
Varesco, L.2
Favoni, R.3
Ferrara, G.B.4
Moro, F.5
Ottaggio, L.6
Fronza, G.7
Campomenosi, P.8
Abbondandolo, A.9
Cutrona, G.10
Roncella, S.11
Albini, A.12
Aluigi, M.G.13
Pozzi, S.14
Pera, C.15
Biticchi, R.16
Gismondi, V.17
Grossi, F.18
Pennucci, M.C.19
Ardizzoni, A.20
more..
-
51
-
-
76649138588
-
The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells
-
Fernando RI, Litzinger M, Trono P, et al. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells. J Clin Invest 2010;120: 533-544.
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 533-544
-
-
Fernando, R.I.1
Litzinger, M.2
Trono, P.3
-
52
-
-
84873075505
-
Oncogenic KRASinduced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer
-
Epub ahead of print
-
Sunaga N, Imai H, Shimizu K, et al. Oncogenic KRASinduced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer. Int J Cancer 2011. Epub ahead of print.
-
(2011)
Int. J. Cancer
-
-
Sunaga, N.1
Imai, H.2
Shimizu, K.3
-
53
-
-
77956178360
-
EMT cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer
-
Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010;29:4741-4751.
-
(2010)
Oncogene
, vol.29
, pp. 4741-4751
-
-
Singh, A.1
Settleman, J.2
-
54
-
-
0036716281
-
The BCL2 family: Regulators of the cellular life-or-death switch
-
DOI 10.1038/nrc883
-
Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2002;2:647-656. (Pubitemid 37328916)
-
(2002)
Nature Reviews Cancer
, vol.2
, Issue.9
, pp. 647-656
-
-
Cory, S.1
Adams, J.M.2
-
55
-
-
17144427727
-
Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo
-
DOI 10.1038/sj.cdd.4401563
-
Huber C, Bobek N, Kuball J, et al. Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo. Cell Death Differ 2005;12:317-325. (Pubitemid 40520683)
-
(2005)
Cell Death and Differentiation
, vol.12
, Issue.4
, pp. 317-325
-
-
Huber, C.1
Bobek, N.2
Kuball, J.3
Thaler, S.4
Hoffarth, S.5
Huber, C.6
Theobald, M.7
Schuler, M.8
-
56
-
-
68949202516
-
Role of the unfolded protein response regulator GRP78/BiP in development cancer and neurological disorders
-
Wang M, Wey S, Zhang Y, et al. Role of the unfolded protein response regulator GRP78/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal 2009;11:2307-2316.
-
(2009)
Antioxid Redox. Signal
, vol.11
, pp. 2307-2316
-
-
Wang, M.1
Wey, S.2
Zhang, Y.3
-
57
-
-
84873069349
-
PUMA chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x L and Mcl-1
-
Epub ahead of print.
-
Yuan Z, Cao K, Lin C, et al. PUMA chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1. Mol Med 2011. Epub ahead of print.
-
(2011)
Mol. Med.
-
-
Yuan, Z.1
Cao, K.2
Lin, C.3
-
58
-
-
34547852249
-
Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data
-
DOI 10.1093/bioinformatics/btm188
-
Dawelbait G, Winter C, Zhang Y, et al. Structural templates predict novel protein interactions and targets from pancreas tumour gene expression data. Bioinformatics 2007;23: i115-124. (Pubitemid 47244392)
-
(2007)
Bioinformatics
, vol.23
, Issue.13
-
-
Dawelbait, G.1
Winter, C.2
Zhang, Y.3
Pilarsky, C.4
Grutzmann, R.5
Heinrich, J.-C.6
Schroeder, M.7
-
60
-
-
78049518977
-
TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
-
Wang S, Xiao X, Zhou X, et al. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer 2010;10:617.
-
(2010)
BMC Cancer
, vol.10
, pp. 617
-
-
Wang, S.1
Xiao, X.2
Zhou, X.3
-
61
-
-
79251610744
-
RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA
-
Zhang K, Chen D, Wang X, et al. RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA. Int J Mol Sci 2011;12: 385-400.
-
(2011)
Int. J. Mol. Sci.
, vol.12
, pp. 385-400
-
-
Zhang, K.1
Chen, D.2
Wang, X.3
-
62
-
-
80053353709
-
Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy
-
Hannani D, Sistigu A, Kepp O, et al. Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy. Cancer J 2011;17:351-358.
-
(2011)
Cancer J.
, vol.17
, pp. 351-358
-
-
Hannani, D.1
Sistigu, A.2
Kepp, O.3
-
64
-
-
20044382627
-
Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules
-
DOI 10.1158/1078-0432.CCR-04-1609
-
Tsang KY, Palena C, Yokokawa J, et al. Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules. Clin Cancer Res 2005;11:1597-1607. (Pubitemid 40315245)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.4
, pp. 1597-1607
-
-
Tsang, K.Y.1
Palena, C.2
Yokokawa, J.3
Arlen, P.M.4
Gulley, J.L.5
Mazzara, G.P.6
Gritz, L.7
Gomez Yafal, A.8
Ogueta, S.9
Greenhalgh, P.10
Manson, K.11
Panicali, D.12
Schlom, J.13
-
65
-
-
0023812898
-
Release of carcinoembryonic antigen from human colon cancer cells by phosphatidylinositol- specific phospholipase C
-
Sack TL, Gum JR, Low MG, Kim YS. Release of carcinoembryonic antigen from human colon cancer cells by phosphatidylinositol- specific phospholipase C. J Clin Invest. 1988;82:586-593.
-
(1988)
J. Clin. Invest.
, vol.82
, pp. 586-593
-
-
Sack, T.L.1
Gum, J.R.2
Low, M.G.3
Kim, Y.S.4
-
67
-
-
79956318603
-
TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT
-
Lalaoui N, Morle A, Merino D, et al. TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT. PloS one. 2011;6:e19679.
-
(2011)
PloS One.
, vol.6
-
-
Lalaoui, N.1
Morle, A.2
Merino, D.3
|